Short-term and Long-term Exposure of the MucilAir™ Model to Polycyclic Aromatic Hydrocarbons

Abstract

Cells grown in monocultures are widely used to model lung tissue. As a result of these culture conditions, these cells exhibit poor morphological similarity to those present in in vivo lung tissue. MucilAir™, a 3-D in vitro model comprising human basal, goblet and ciliated cells, represents a fully differentiated respiratory epithelium that can be used as an alternative and a more realistic system. The aim of our study was to compare the effects of short-term and long-term exposure to two polycyclic aromatic hydrocarbons (PAHs) — benzo[a]pyrene (B[a]P) and 3-nitrobenzanthrone (3-NBA) — using MucilAir as a model of human lung tissue. Two concentrations (0.1 μM and 1 μM) were tested at three time points (24 hours, 7 days and 28 days). Several aspects were assessed: cytotoxicity (lactate dehydrogenase (LDH) release), integrity of the cell layer (transepithelial electrical resistance (TEER)), induction of oxidative stress (reactive oxygen species production) and changes in the expression of selected genes involved in PAH metabolism (CYP1A1 and AKR1C2) and the antioxidant response (ALDH3A1, SOD1, SOD2, GPX1, CAT, HMOX1 and TXNRD1). The results showed that exposure to B[a]P caused a spike in LDH release at day 5. Exposure to 3-NBA caused a number of spikes in LDH release, starting at day 5, and a decrease in TEER after 11 days. CYP1A1 gene expression was upregulated after the 7-day and 28-day B[a]P exposures, as well as after the 24-hour and 7-day 3-NBA exposures. HMOX1 and SOD1 were downregulated after both 24-hour PAH treatments. HMOX1 was upregulated after a 1-week exposure to 3-NBA. There were no significant changes in the messenger RNA (mRNA) levels of AKR1C2, ALDH3A1, TXNRD1, SOD2, GPX1 or CAT. These results illustrate the potential use of this 3-D in vitro lung tissue model in studying the effects of chronic exposure to PAHs.

Keywords

3-D cell culture 3-nitrobenzanthrone benzo[a]pyrene cytotoxicity gene expression lung oxidative stress

Get full access to this article

View all access options for this article.

References

Flecknell

. Replacement, reduction and refinement. ALTEX 2002; 19: 73–78.

Sueki

Matsuda

Iwashita

. Epithelial-mesenchymal transition of A549 cells is enhanced by co-cultured with THP-1 macrophages under hypoxic conditions. Biochem Biophys Res Commun 2014; 453: 804–809.

Hittinger

Janke

Huwer

. Autologous co-culture of primary human alveolar macrophages and epithelial cells for investigating aerosol medicines. Part I: model characterisation. Altern Lab Anim 2016; 44: 337–347.

McKim

. The Journal of Applied In Vitro Toxicology: Its time has come! Appl Vitro Toxicol 2015; 1: 1–4.

Huang

Wiszniewski

Constant

. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir™) to assess respiratory sensitizers. Toxicol Vitro 2013; 27: 1151–1156.

Huang

Boda

Vernaz

. Establishment and characterization of an in vitro human small airway model (SmallAir™). Eur J Pharm Biopharm 2017; 118: 68–72.

Frieke Kuper

Gröllers-Mulderij

Maarschalkerweerd

. Toxicity assessment of aggregated/agglomerated cerium oxide nanoparticles in an in vitro 3D airway model: the influence of mucociliary clearance. Toxicol Vitro 2015; 29: 389–397.

Kooter

Gröllers-Mulderij

Steenhof

. Cellular effects in an in vitro human 3D cellular airway model and A549/BEAS-2B in vitro cell cultures following air exposure to cerium oxide particles at an air–liquid interface. Appl Vitro Toxicol 2016; 2: 56–66.

Zavala

O’Brien

Lichtveld

. Assessment of biological responses of EpiAirway 3-D cell constructs versus A549 cells for determining toxicity of ambient air pollution. Inhal Toxicol 2016; 28: 251–259.

10.

Metz

Knoth

Groß

. Combining MucilAir™ and Vitrocell^® powder chamber for the in vitro evaluation of nasal ointments in the context of aerosolized pollen. Pharmaceutics 2018; 10: 56.

11.

Srinivasan

Reddy Kolli

Esch

. TEER measurement techniques for in vitro barrier model systems. J Lab Autom 2015; 20: 107–126.

12.

IARC. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Volume 100F: chemical agents and related occupations. Lyon: International Agency for Research on Cancer, 2012, pp. 599.

13.

IARC. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Volume 105: diesel and gasoline engine exhausts and some nitroarenes. Lyon: International Agency for Research on Cancer, 2014, p. 703.

14.

Rossner

Jr Libalova

Cervena

. The processes associated with lipid peroxidation in human embryonic lung fibroblasts, treated with polycyclic aromatic hydrocarbons and organic extract from particulate matter. Mutagenesis 2019. [in press].

15.

Mcglashan

Shaikh

. Measurement of reactive oxygen species in the culture media using Acridan Lumigen PS-3 assay. J Biomol Tech 2011; 22: 95–107.

16.

Livak

Schmittgen

. Analysis of relative gene expression data using real-time quantitative PCR and the 2^−▵▵Ct method. Methods 2001; 25: 402–408.

17.

Hanzalova

Rossner

Sram

. Oxidative damage induced by carcinogenic polycyclic aromatic hydrocarbons and organic extracts from urban air particulate matter. Mutat Res Genet Toxicol Environ Mutagen 2010; 696: 114–121.

18.

Rossner

Jr Mrhalkova

Uhlirova

. Nucleotide excision repair is not induced in human embryonic lung fibroblasts treated with environmental pollutants. PLoS One 2013; 8: e69197.

19.

Rossner

Jr Rossnerova

Beskid

. Nonhomologous DNA end joining and chromosome aberrations in human embryonic lung fibroblasts treated with environmental pollutants. Mutat Res 2014; 763–764: 28–38.

20.

Rossner

Strapacova

Stolcpartova

. Toxic effects of the major components of diesel exhaust in human alveolar basal epithelial cells (A549). Int J Mol Sci 2016; 17: 1393.

21.

Libalova

Milcova

Cervena

. Kinetics of ROS generation induced by polycyclic aromatic hydrocarbons and organic extracts from ambient air particulate matter in model human lung cell lines. Mutat Res Genet Toxicol Environ Mutagen 2018; 827: 50–58.

22.

De Servi

Ranzini

Piqué

. Protective barrier properties of Rhinosectan^® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study. Allerg Asthma Clin Immunol 2017; 13: 37.

23.

Kooter

Gröllers-Mulderij

Duistermaat

. Factors of concern in a human 3D cellular airway model exposed to aerosols of nanoparticles. Toxicol Vitro 2017; 44: 339–348.

24.

Bisig

Comte

Güdel

. Assessment of lung cell toxicity of various gasoline engine exhausts using a versatile in vitro exposure system. Environ Pollut 2018; 235: 263–271.

25.

Dankers

ACA

Kuper

Boumeester

. A practical approach to assess inhalation toxicity of metal oxide nanoparticles in vitro. J Appl Toxicol 2018; 38: 160–171.

26.

Boublil

Assémat

Borot

. Development of a repeated exposure protocol of human bronchial epithelium in vitro to study the long-term effects of atmospheric particles. Toxicol Vitro 2013; 27: 533–542.

27.

Aufderheide

Scheffler

Ito

. Ciliatoxicity in human primary bronchiolar epithelial cells after repeated exposure at the air–liquid interface with native mainstream smoke of K3R4F cigarettes with and without charcoal filter. Exp Toxicol Pathol 2015; 67: 407–411.

28.

Gostner

Zeisler

Alam

. Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep 2016; 6: 1–14.

29.

Crespin

Bacchetta

Bou Saab

. Cx26 regulates proliferation of repairing basal airway epithelial cells. Int J Biochem Cell Biol 2014; 52: 152–160.

30.

Evans

Clift

Singh

. Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity. Mutagenesis 2017; 32: 233–241.

31.

Kirkland

. Improvements in the reliability of in vitro genotoxicity testing. Exp Opin Drug Metab Toxicol 2011; 7: 1513–1520.

32.

Jennings

. The future of in vitro toxicology. Toxicol Vitro 2015; 29: 1217–1221.

33.

Rothen-Rutishauser

Blank

Mühlfeld

. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Exp Opin Drug Metab Toxicol 2008; 4: 1075–1089.